Comparison of Bayesian-derived and first-order analytic equations for calculation of vancomycin area under the curve.


Journal

Pharmacotherapy
ISSN: 1875-9114
Titre abrégé: Pharmacotherapy
Pays: United States
ID NLM: 8111305

Informations de publication

Date de publication:
04 2022
Historique:
revised: 10 12 2021
received: 02 11 2021
accepted: 10 12 2021
pubmed: 9 2 2022
medline: 20 4 2022
entrez: 8 2 2022
Statut: ppublish

Résumé

Consensus guidelines recommend targeting a vancomycin area under the curve to minimum inhibitory concentration (AUC To compare calculated vancomycin AUC This was a single-center, retrospective cohort study of 978 adult hospitalized patients receiving intravenous vancomycin between 2017 and 2019. Patients were included if they received at least 72 h of vancomycin and had two-serum drug concentrations obtained. AUC Excellent agreement was observed between linear and Bayesian two-concentration methods (r = 0.963, clinical agreement = 87.4%) and Bayesian two-concentration and one-concentration methods (r = 0.931, clinical agreement = 88.5%); however, a degree of variability was noted with 95% LOA -99 to 76 (MD = -11.5 mg*h/L) and -92 to 113 (MD = -10.4 mg*h/L), for the respective comparisons. The agreement between linear and Bayesian one-concentration approaches was less than prior comparisons (r = 0.823, clinical agreement = 76.8%) and demonstrated the greatest amount of variability with 95% LOA -197 to 153 (MD = -21.9 mg*h/L). Linear and Bayesian two-concentration methods demonstrated high-level agreement with acceptable variability and may be considered comparable to estimate vancomycin AUC

Identifiants

pubmed: 35134264
doi: 10.1002/phar.2670
pmc: PMC9750735
mid: NIHMS1854577
doi:

Substances chimiques

Anti-Bacterial Agents 0
Vancomycin 6Q205EH1VU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

284-291

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK128562
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001998
Pays : United States

Informations de copyright

© 2022 Pharmacotherapy Publications, Inc.

Références

J Antimicrob Chemother. 1990 Apr;25(4):679-87
pubmed: 2351627
J Antimicrob Chemother. 2009 May;63(5):1050-7
pubmed: 19299472
Open Forum Infect Dis. 2021 Mar 12;8(5):ofab094
pubmed: 34046514
Pharmacotherapy. 2014 Jul;34(7):670-6
pubmed: 24855041
J Pharmacokinet Pharmacodyn. 2004 Feb;31(1):75-107
pubmed: 15346853
Ther Drug Monit. 1989;11(4):450-4
pubmed: 2741194
Clin Microbiol Infect. 2021 Sep;27(9):1346.e1-1346.e7
pubmed: 33221430
Antimicrob Agents Chemother. 2008 Apr;52(4):1330-6
pubmed: 18227177
BMC Pharmacol Toxicol. 2013 Feb 13;14:12
pubmed: 23402420
Ther Adv Endocrinol Metab. 2016 Jun;7(3):136-47
pubmed: 27293542
Pharmacotherapy. 2018 Dec;38(12):1174-1183
pubmed: 30362592
Ther Drug Monit. 2018 Apr;40(2):212-221
pubmed: 29470227
Pharmacotherapy. 2014 Dec;34(12):1259-68
pubmed: 25220436
PLoS One. 2018 Sep 6;13(9):e0203453
pubmed: 30188918
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28289024
Clin Pharmacokinet. 2004;43(13):925-42
pubmed: 15509186
Crit Care Med. 2021 Oct 1;49(10):e952-e960
pubmed: 33938713
PLoS One. 2016 Jan 05;11(1):e0146224
pubmed: 26731739
Ann Pharmacother. 1994 Dec;28(12):1335-9
pubmed: 7696720
Int J Antimicrob Agents. 2015 Dec;46(6):689-95
pubmed: 26555059
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28242672
Antimicrob Agents Chemother. 1988 Jun;32(6):848-52
pubmed: 3415206
Adv Drug Deliv Rev. 2014 Nov 20;77:50-7
pubmed: 24910345
Pharmacotherapy. 2014 Jul;34(7):662-9
pubmed: 24753221
Antimicrob Agents Chemother. 2013 Feb;57(2):734-44
pubmed: 23165462
Surg Infect (Larchmt). 2015 Dec;16(6):684-93
pubmed: 26324996
Antimicrob Agents Chemother. 2005 Dec;49(12):4934-41
pubmed: 16304155
BMC Infect Dis. 2021 Feb 6;21(1):153
pubmed: 33549035
Antimicrob Agents Chemother. 2014;58(1):309-16
pubmed: 24165176
Am J Health Syst Pharm. 2020 May 19;77(11):835-864
pubmed: 32191793

Auteurs

Katie B Olney (KB)

Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky, USA.
Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.

Katie L Wallace (KL)

Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky, USA.
Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.

Ryan P Mynatt (RP)

Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky, USA.

David S Burgess (DS)

Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.

Kaitlyn Grieves (K)

Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.

Austin Willett (A)

Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.

Johann Mani (J)

Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.

Alexander H Flannery (AH)

Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky, USA.
Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH